Abstract:Epigenetic gene regulations can be considered as de-novo initiation of abnormal molecular signaling events whose regulation is otherwise required during normal or specific developmental stages of the organisms. Primarily, three different mechanisms have been identified to participate in epigenetic gene regulations which include, DNA methylation, non-coding RNA species (microRNAs [miRNA], and long non-coding RNAs [LNC-RNA]) and histone modifications. These de-novo epigenetic mechanisms have been associated with altered normal cellular functions which eventually facilitate normal cells to transition into an abnormal phenotype. Among the three modes of regulation, RNA species which are usually considered to be less stable, can be speculated to initiate instant alterations in gene expression compared to DNA methylation or histone modifications. However, LNC-RNAs appear to be more stable in the cells than the other RNA species. Moreover, there is increasing literature which clearly suggests that a single specific LNC-RNA can regulate multiple mechanisms and disease phenotypes. With specific focus on cardiovascular diseases, here we attempt to provide UpToDate information on the functional role of miRNAs and LNC-RNAs. Here we discuss the role of these epigenetic mediators in different components of cardiovascular disease which include physiopathological heart development, athersclerosis, retenosis, diabetic hearts, myocardial infarction, ischemia-reperfusion, heart valve disease, aortic aneurysm, osteogenesis, angiogenesis and hypoxia in the heart. While there is abundant literature support that shows the involvement of many LNC-RNAs and miRNAs in cardiovascular diseases, very few RNA species have been identified which regulate epigenetic mechanisms which is the current focus in this article. Understanding the role of these RNA species in regulating epigenetic mechanisms in different cell types causing cardiovascular disease, would advance the field and promote disease prevention approaches that are aimed to target epigenetic mechanisms.

Noncoding RNAs in the Vascular System Response to Oxidative Stress

Circular RNAs: Novel Players in the Oxidative Stress-Mediated Pathologies, Biomarkers, and Therapeutic Targets

Emerging Clues of Regulatory Roles of Circular RNAs Through Modulating Oxidative Stress: Focus on Neurological and Vascular Diseases.

Central role of the p53 pathway in the noncoding-RNA response to oxidative stress

LncRNAs Are Key Regulators of Transcription Factor-Mediated Endothelial Stress Responses

The Importance of NADPH Oxidases and Redox Signaling in Angiogenesis

Long Noncoding RNAs in the Regulation of Oxidative Stress

Pathophysiology of Ischemic Stroke: Noncoding RNA Role in Oxidative Stress

Noncoding RNAs in Vascular Aging

The Emerging Role of GSNOR in Oxidative Stress Regulation

Oxidative and Nitrous Stress Underlies Vascular Malfunction Induced by Ionizing Radiation and Diabetes

Long Non-Coding RNA Regulation of Epigenetics in Vascular Cells

Reactive Oxygen Species and Oxidative Stress in Vascular-Related Diseases

The crosstalk between reactive oxygen species and noncoding RNAs: from cancer code to drug role

Cardiovascular Disease and miRNAs: Possible Oxidative Stress-Regulating Roles of miRNAs

Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature

Non-coding RNAs as Epigenetic Gene Regulators in Cardiovascular Diseases

Noncoding RNAs in Vascular Diseases

Reactive oxygen species: physiological roles in the regulation of vascular cells

Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs

NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets